rs5030737

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001378373.1(MBL2):​c.154C>T​(p.Arg52Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0644 in 1,613,662 control chromosomes in the GnomAD database, including 3,819 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.049 ( 282 hom., cov: 32)
Exomes 𝑓: 0.066 ( 3537 hom. )

Consequence

MBL2
NM_001378373.1 missense

Scores

5
6
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:1B:3O:1

Conservation

PhyloP100: 0.972

Publications

266 publications found
Variant links:
Genes affected
MBL2 (HGNC:6922): (mannose binding lectin 2) This gene encodes the soluble mannose-binding lectin or mannose-binding protein found in serum. The protein encoded belongs to the collectin family and is an important element in the innate immune system. The protein recognizes and binds to mannose and N-acetylglucosamine on many microorganisms, including bacteria, yeast, and viruses including influenza virus, HIV and SARS-CoV. This binding activates the classical complement pathway. Deficiencies of this gene have been associated with susceptibility to autoimmune and infectious diseases. [provided by RefSeq, Jun 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030004382).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0705 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MBL2NM_001378373.1 linkc.154C>T p.Arg52Cys missense_variant Exon 2 of 5 ENST00000674931.1 NP_001365302.1
MBL2NM_000242.3 linkc.154C>T p.Arg52Cys missense_variant Exon 1 of 4 NP_000233.1
MBL2NM_001378374.1 linkc.154C>T p.Arg52Cys missense_variant Exon 2 of 5 NP_001365303.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MBL2ENST00000674931.1 linkc.154C>T p.Arg52Cys missense_variant Exon 2 of 5 NM_001378373.1 ENSP00000502789.1
MBL2ENST00000373968.3 linkc.154C>T p.Arg52Cys missense_variant Exon 1 of 4 1 ENSP00000363079.3
MBL2ENST00000675947.1 linkc.154C>T p.Arg52Cys missense_variant Exon 2 of 5 ENSP00000502615.1

Frequencies

GnomAD3 genomes
AF:
0.0494
AC:
7514
AN:
152044
Hom.:
282
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0119
Gnomad AMI
AF:
0.157
Gnomad AMR
AF:
0.0388
Gnomad ASJ
AF:
0.0991
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0567
Gnomad FIN
AF:
0.0609
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0722
Gnomad OTH
AF:
0.0503
GnomAD2 exomes
AF:
0.0556
AC:
13955
AN:
251104
AF XY:
0.0585
show subpopulations
Gnomad AFR exome
AF:
0.0107
Gnomad AMR exome
AF:
0.0255
Gnomad ASJ exome
AF:
0.103
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.0580
Gnomad NFE exome
AF:
0.0736
Gnomad OTH exome
AF:
0.0559
GnomAD4 exome
AF:
0.0659
AC:
96331
AN:
1461500
Hom.:
3537
Cov.:
33
AF XY:
0.0665
AC XY:
48339
AN XY:
727066
show subpopulations
African (AFR)
AF:
0.00992
AC:
332
AN:
33472
American (AMR)
AF:
0.0272
AC:
1218
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
2711
AN:
26110
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39698
South Asian (SAS)
AF:
0.0602
AC:
5193
AN:
86242
European-Finnish (FIN)
AF:
0.0576
AC:
3077
AN:
53420
Middle Eastern (MID)
AF:
0.0735
AC:
422
AN:
5744
European-Non Finnish (NFE)
AF:
0.0717
AC:
79674
AN:
1111726
Other (OTH)
AF:
0.0612
AC:
3696
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
4355
8710
13065
17420
21775
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2890
5780
8670
11560
14450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0494
AC:
7513
AN:
152162
Hom.:
282
Cov.:
32
AF XY:
0.0486
AC XY:
3613
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.0118
AC:
491
AN:
41520
American (AMR)
AF:
0.0387
AC:
592
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0991
AC:
343
AN:
3460
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5164
South Asian (SAS)
AF:
0.0567
AC:
274
AN:
4830
European-Finnish (FIN)
AF:
0.0609
AC:
644
AN:
10578
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0722
AC:
4912
AN:
68006
Other (OTH)
AF:
0.0498
AC:
105
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
350
700
1050
1400
1750
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0629
Hom.:
1489
Bravo
AF:
0.0463
TwinsUK
AF:
0.0690
AC:
256
ALSPAC
AF:
0.0714
AC:
275
ESP6500AA
AF:
0.0118
AC:
52
ESP6500EA
AF:
0.0693
AC:
596
ExAC
AF:
0.0570
AC:
6914
Asia WGS
AF:
0.0250
AC:
87
AN:
3478
EpiCase
AF:
0.0689
EpiControl
AF:
0.0747

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1Benign:3Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Mannose-binding lectin deficiency Pathogenic:2Benign:2
Dec 11, 2018
Illumina Laboratory Services, Illumina
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The MLB2 c.154C>T (p.Arg52Cys) missense variant, commonly referred to as the "D" allele, has been described in at least one study in individuals with recurrent infections and low serum MBP levels in which it was found in a compound heterozygous state with another missense variant in one individual with a very low serum MBP level and in a homozygous state in another individual with no detectable serum MBP level (Summerfield et al. 1995). The p.Arg52Cys variant has also been investigated in healthy unrelated individuals with low or undetectable MBP levels (Madsen et al. 1994; Babovic-Vuksanovic et al. 1999) and found at a frequency of 0.05 in both the African and Caucasian populations in both a compound heterozygous state and a heterozygous state. Functional studies by Liu et al. (2012) showed that the p.Arg52Cys variant did not affect gene transcription or protein secretion, but did result in a lower level of oligomerization, a loss of ability to bind mannan, a reduced ability to bind to MASP1 and MASP2 and failed to activate the complement system. However, it should be noted that MBL deficiency is very common. The p.Arg52Cys variant is reported at a frequency of is 0.11111 in the Finnish population of the 1000 Genomes Project. While the allele frequency for this variant appears to be high, multiple studies referenced in this paragraph have shown a significant over-representation of this variant in individuals with low levels of mannose-binding lectin as compared to controls. Many individuals who carry MBL2 variants classified as pathogenic do not develop clinical complications. Based on the evidence, the p.Arg52Cys variant is classified as pathogenic for mannose-binding lectin deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -

Aug 01, 2006
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Mar 26, 2024
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

not provided Uncertain:1Benign:1
Jul 01, 2021
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cystic fibrosis Other:1
Apr 01, 2019
Center for Computational Genomics and Data Science, University of Alabama
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Uncertain
-0.030
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.62
D
Eigen
Uncertain
0.38
Eigen_PC
Benign
0.19
FATHMM_MKL
Benign
0.091
N
LIST_S2
Pathogenic
0.97
D
MetaRNN
Benign
0.0030
T
MetaSVM
Uncertain
0.062
D
MutationAssessor
Pathogenic
3.4
M
PhyloP100
0.97
PrimateAI
Benign
0.33
T
PROVEAN
Pathogenic
-4.9
D
REVEL
Uncertain
0.53
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0040
D
Polyphen
1.0
D
Vest4
0.091
MPC
0.50
ClinPred
0.067
T
GERP RS
3.1
PromoterAI
-0.021
Neutral
Varity_R
0.59
gMVP
0.42
Mutation Taster
=85/15
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030737; hg19: chr10-54531242; COSMIC: COSV64758368; API